Fortitude Family Office »

Zentalis Pharmaceuticals shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2026-03-31 $488 209 2.34

More positions owned by Fortitude Family Office

Ishares Core S&p 500 Etf Etf (IVV)
Avantis Total Equity Markets Etf Etf (AVTM)
Vanguard 0-3 Month Treasury Bill Etf Etf (VBIL)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Apple Stock (AAPL)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Mid-cap Etf Etf (VO)
Vanguard S&p 500 Etf Etf (VOO)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Invesco Senior Loan Etf Etf (BKLN)
Avantis International Small Cap Value Etf Etf (AVDV)

View all positions for Fortitude Family Office

Top funds holding Zentalis Pharmaceuticals

Squadron Capital Management
5AM Venture Management
Two Sigma Investments
Vanguard Group
Acadian Asset Management
Vanguard Capital Management
Renaissance Technologies
Citadel Advisors
D. E. Shaw & Co
Opaleye Management
Decheng Capital
Millennium Management
BlackRock
Bank of America Corporation
PRIMECAP Management Company

View all funds holding Zentalis Pharmaceuticals